15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Innoviva Inc, 4 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $17.00 to $46.00 (about 2.7x), a sign of real disagreement on valuation. The average target of $34.20 sits 57% above the current $21.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.46 next quarter toward $2.21 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy480%
Hold00%
Sell120%
Strong Sell00%
Based on 5 analysts giving stock ratings to Innoviva Inc.
As of Jul, 4 of 5 firms rate INVA a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
INVA EPS & revenue forecast
EPS · NEXT QUARTER
$0.46
Range $0.46 – $0.46 · 1 analysts · +20% YoY
Next period, 1 analysts expect Innoviva Inc to earn $0.46 a share (range $0.46 – $0.46), versus $0.38 a year earlier. Full-year consensus is $1.91, growing to $2.21 the year after.
REVENUE · NEXT QUARTER
$113.5M
Range $109.1M – $119.8M · 1 analysts · +5% YoY
Revenue is expected to reach $113.5M (range $109.1M – $119.8M), +5.3% year-over-year. Full-year consensus is $440.6M, rising to $486.1M next year.
Top analysts covering Innoviva Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INVA.
#1
Louise Chen
Cantor Fitzgerald · Rank #156
Buy
No targeton INVA
Overall win rate
43%
+ Follow
#2
Raghuram Selvaraju
HC Wainwright & Co. · Rank #249
Buy
$46.00+111.0% to target
Overall win rate
37%
+ Follow
#3
Julian Harrison
BTIG
Buy
$42.00+92.7% to target
Coverage
—
+ Follow
#4
TA
Trevor Allred
Oppenheimer
Buy
$35.00+60.6% to target
Coverage
—
+ Follow
#5
SS
Steve Seedhouse
Cantor Fitzgerald
Buy
$31.00+42.2% to target
Coverage
—
+ Follow
INVA stock forecast FAQ
What is INVA's average 12-month price target?+
The 5 analysts with a live target average $34.20 for Innoviva Inc over the next 12 months, ranging from a $46.00 high to a $17.00 low.
Is INVA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for INVA?+
The Street-high target is $46.00 (HC Wainwright & Co.), and the Street-low is $17.00 (Goldman Sachs). The average of all 5 active targets is $34.20.
How many Wall Street analysts cover INVA?+
5 analysts have an active rating on Innoviva Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering INVA?+
Among analysts who currently cover INVA, Louise Chen of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #156). Their current call is Buy.
What is Innoviva Inc's projected EPS for next quarter?+
The consensus estimate is $0.46 per share (range $0.46 – $0.46) across 1 analysts. Full-year EPS is projected at $1.91, rising to $2.21 the following year.
How much revenue is Innoviva Inc expected to report next quarter?+
Consensus revenue is $113.5M (range $109.1M – $119.8M). Full-year revenue is projected at $440.6M, growing to $486.1M next year.
Have analysts been upgrading or downgrading INVA lately?+
As of Jul, 4 of 5 firms rate INVA a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INVA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
